|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Anti-Cancer Drug Discovery and Development Summit | ||||||||||||||||
May 16, 2001 | ||||||||||||||||
Strategic Research Institute, 236 West 27th Street, 8th Floor, NY, NY 10001 June 11-12, 2001 ORGANIZED INTO 5 SECTIONS: -NEW MOLECULAR TARGETS -THERAPEUTIC ANTIBODIES -APPLIED GENOMICS IN CANCER -ANGIOGENIC ADVANCES -NOVEL THERAPEUTICS FEATURING: Protein kinases as targets for novel anti-cancer agents NOVARTIS Molecular medicine and clinical development of a novel proteasome inhibitor in cancer MILLENNIUM PHARMACEUTICALS Application of genomics & proteomics to the development of diagnostics and therapeutics for cancer CELERA GENOMICS Identification of mitotic kinesin inhibitors as novel cancer therapeutics CYTOKINETICS |
||||||||||||||||
Organized by: | to register call 1-888-666-8514 | |||||||||||||||
Invited Speakers: | chief scientists, medical advisors, senior researchers, and other associates | |||||||||||||||
Deadline for Abstracts: | abstracts have already been announced | |||||||||||||||
Registration: | to register call 1-888-666-8514 | |||||||||||||||
E-mail: | www.esingleton@srinstitute.com | |||||||||||||||
Posted by: | EDRILON | |||||||||||||||
Host: | 12.3.58.10 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |